PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)
$1.34 -0.01 (-0.7407%)
Analysed PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) News Sources
GEHC Unifies bkActiv With Stealth AXiS for Live Neurosurgery Imaging
10-04-2026
yahoo.com
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
09-04-2026
yahoo.com
BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension
09-04-2026
yahoo.com
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
08-04-2026
yahoo.com
GRAIL Partners With Epic to Broaden Galleri Test Access Across US
08-04-2026
yahoo.com
Here's Why You Should Add Inspire Medical Stock to Your Portfolio Now
08-04-2026
yahoo.com
Artivion Secures FDA Approval for NEXUS Aortic Arch System
08-04-2026
yahoo.com
Pacific Biosciences of California (PACB) Laps the Stock Market: Here's Why
07-04-2026
yahoo.com
STXS Gains on FDA Nod for Synchrony System, Expands Digital Surgery
07-04-2026
yahoo.com
Revvity Gains on Diagnostics Strength, Faces China Headwinds
06-04-2026
yahoo.com
What is the current price of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)?
The current price of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) is $1.34.
PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) absolute price change since previous trading day?
The absolute price change of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) since the previous trading day is $-0.01.
PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) percentage price change since previous trading day?
The percentage price change of PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) since the previous trading day is -0.7407%.
What is the most recent average sentiment score for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)?
The most recent average sentiment score for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)?
The most recent sentiment for PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ) is .
SEC-8K** Filing Available For PACIFIC BIOSCIENCES OF CALIF (PACB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.